Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea · Delayed Price · Currency is KRW 4,900.00
-60.00 (-1.21%)
At close: Oct 23, 2026
Kyung Dong Pharmaceutical Market Cap
Kyung Dong Pharmaceutical has a market cap or net worth of 143.57 billion as of October 23, 2026. It is the 24,546th most valuable company in the world and the 1,022nd biggest in South Korea. Its market cap has decreased by 8.75% in one year.
Market Cap
143.57B
Enterprise Value
141.80B
Revenue
201.12B
Global Rank
Country Rank
#1,022 South Korea
PE Ratio
7.57
ChartMarket Cap Chart
Since January 29, 2001, Kyung Dong Pharmaceutical's market cap has increased from 44.35B to 143.57B, an increase of 223.71%. That is a compound annual growth rate of 4.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 143.57B | -8.75% |
| Dec 30, 2025 | 157.34B | -4.73% |
| Dec 30, 2024 | 165.15B | -7.92% |
| Dec 28, 2023 | 179.35B | -16.01% |
| Dec 29, 2022 | 213.54B | -31.89% |
| Dec 30, 2021 | 313.54B | 1.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 202.94B |
| GC WellBeing | 192.85B |
| DAE HWA Pharmaceutical | 184.96B |
| Vivozon Pharmaceutical | 178.69B |
| NOVAREX | 167.72B |
| CellBion | 158.09B |
| HYUNDAI BIOLAND | 132.15B |
| PHARMARESEARCH BIO | 121.87B |